BioCentury
ARTICLE | Distillery Therapeutics

Cancer

July 18, 2017 9:05 PM UTC

Patient sample, in vitro, cell culture and mouse studies identified a benzamide-based CSNK1A activator that could help treat Wnt signaling-driven colorectal cancer. In colorectal cancer patients, low ...

BCIQ Company Profiles

University of Miami